Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Neurology · COQ8A-Related Ataxia

Building Your Care Team and Daily Management

At a Glance

People with COQ8A-related ataxia benefit from a coordinated team led by neurology, with metabolic specialists and therapists involved. Individualized exercise, symptom-based heart and kidney checks, swallowing assessment when warning signs appear, and a shared emergency plan support daily safety.

Managing COQ8A-related ataxia (ARCA2) requires moving beyond a single doctor to building a “medical home”—a team of specialists who understand that this is a metabolic disease affecting the whole body [1][2]. Because the condition is so rare, your care team will often combine COQ8A-specific research with broader strategies used for mitochondrial diseases and other hereditary ataxias [1].

Your Multidisciplinary Team

A comprehensive care team should include the following specialists to monitor the different ways the CoQ10 deficiency can manifest:

  • Neurologist (Movement Disorder Specialist): The “lead” for managing ataxia, seizures, and involuntary movements. They track progression using tools like the SARA score [3][4].
  • Biochemical Geneticist / Metabolic Specialist: Essential for managing high-dose CoQ10 therapy, monitoring blood levels (like PBMC CoQ10), and adjusting the “metabolic cocktail” if needed [5][6].
  • Cardiologist: Since rare but life-threatening cardiomyopathy (heart muscle thickening) has been reported in COQ8A, an initial echocardiogram and ECG may be considered, with further screening guided by symptoms and specialist advice [7][5].
  • Nephrologist: While uncommon, some patients develop kidney issues like proteinuria (protein in the urine). Early detection is vital because these symptoms can sometimes be reversed with prompt treatment, so referrals are made based on clinical findings [8][5].
  • Therapy Team (PT, OT, SLP): Physical, occupational, and speech therapists focus on day-to-day function, mobility, and safety [9].

Day-to-Day: Exercise and Fatigue

About 25% of people with COQ8A-ataxia experience exercise intolerance [10]. This is a cellular fatigue where the muscles simply run out of “fuel” (ATP) [11].

  • Supervised, Graded Activity: A therapist will design an individualized program that accounts for balance, fatigue, cardiopulmonary findings, nutrition, and recovery rather than high-intensity endurance [12][13].
  • The Power of Routine: Extrapolating from research in broader hereditary ataxias, six weeks of guided physical therapy followed by a consistent home exercise program can significantly improve motor independence [12].
  • Aerobic Benefits: Some studies suggest that moderate aerobic training (like stationary cycling) can improve energy levels and reduce fatigue, provided it is closely monitored to avoid overexertion [14][15].

Managing Speech and Swallowing

As the condition progresses, the muscles involved in speech and swallowing may weaken (dysphagia) [16].

  • Silent Aspiration: This is a potential risk. In related ataxias, some patients “aspirate” (food or liquid entering the lungs) without any outward signs like coughing or choking [17].
  • Formal Assessments: If there are concrete triggers such as recurrent chest infections, a wet voice, coughing with meals, or prolonged meals, an instrumental assessment like a Video Fluoroscopic Swallow Study (VFSS) or Fiberoptic Endoscopic Evaluation of Swallowing (FEES) may be used [18][17].
  • Communication Aids: A Speech-Language Pathologist (SLP) can provide exercises to maintain voice strength and, if necessary, introduce assistive devices to help communicate effectively at school and home [16][19].

Coordinating for the Future

Because many physicians may not be familiar with the nuances of mitochondrial diseases, it is important to maintain a “summary of care” [20]. This document should include the exact COQ8A variants, current CoQ10 dosage, and the “emergency plan” for metabolic crises or prolonged seizures [21][2]. Coordination between your specialists ensures that a treatment for one symptom (like a new medication) doesn’t accidentally worsen another [1][2].

Common questions in this guide

Which specialists are usually involved in COQ8A-related ataxia care?
A neurologist or movement-disorder specialist often leads care for coordination problems, seizures, and involuntary movements. A metabolic or biochemical genetics specialist may manage CoQ10 treatment, while physical, occupational, and speech therapists support movement, daily tasks, communication, and swallowing. Cardiology or nephrology input may be added when heart or kidney concerns arise.
What type of exercise is safest for someone with COQ8A ataxia?
Exercise should be supervised and increased gradually in a program tailored to balance, fatigue, nutrition, recovery, and any heart or lung findings. Moderate aerobic activity, such as stationary cycling, may help some people, but overexertion should be avoided and the plan should be adjusted by a therapist.
When should I ask for a swallowing evaluation?
Ask the care team about a formal evaluation if there is coughing during meals, a wet-sounding voice, unusually long mealtimes, or repeated chest infections. A VFSS or FEES can look for food or liquid entering the lungs, including aspiration that happens without coughing.
Can COQ8A-related ataxia affect the heart or kidneys?
Rarely, people with COQ8A-related ataxia may develop heart muscle disease or protein in the urine. An initial heart ultrasound and electrocardiogram may be considered, while kidney testing and referrals are guided by symptoms and clinical findings.
What should be included in a COQ8A emergency care summary?
Keep a current summary that lists the exact COQ8A gene variants, the current CoQ10 dose, and the emergency plan for metabolic crises or prolonged seizures. Sharing it with every specialist can reduce repeated explanations and help clinicians avoid treatments that could worsen another problem.
How can speech therapy help with COQ8A ataxia?
A speech-language pathologist can provide exercises to support voice strength and assess changes in speaking or swallowing. If communication becomes difficult, the therapist can recommend assistive devices for use at home, school, or work.

Get notified when new evidence is published on Autosomal recessive ataxia due to ubiquinone deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (21)
  1. 1

    [An interpretation of the expert consensus on standards for the management of patients with primary mitochondrial disease from the Mitochondrial Medicine Society].

    Guo Y, Hong SQ, Jiang L

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2018; (20(11)):887-892.

    PMID: 30477617
  2. 2

    Diagnostic Criteria and Management of MELAS and Stroke-Like Episodes: Consensus-Based Statements.

    Mancuso M, Bellusci M, Carelli V, et al.

    European journal of neurology 2026; (33(4)):e70588 doi:10.1111/ene.70588.

    PMID: 41999163
  3. 3

    One-year outcome of coenzyme Q10 supplementation in ADCK3 ataxia (ARCA2).

    Schirinzi T, Favetta M, Romano A, et al.

    Cerebellum & ataxias 2019; (6()):15 doi:10.1186/s40673-019-0109-2.

    PMID: 31890231
  4. 4

    Adult-onset status epilepticus in patients with COQ8A coenzyme Q10 deficiency: A case series.

    Tsalouchidou PE, Juenemann C, Hahn W, et al.

    Epilepsy & behavior reports 2024; (28()):100716 doi:10.1016/j.ebr.2024.100716.

    PMID: 39712550
  5. 5

    Clinical Features, Biochemistry, Imaging, and Treatment Response in a Single-Center Cohort With Coenzyme Q10 Biosynthesis Disorders.

    Wahedi A, Sudhakar S, Lam A, et al.

    Neurology. Genetics 2024; (10(6)):e200209 doi:10.1212/NXG.0000000000200209.

    PMID: 39601013
  6. 6

    Early-onset coenzyme Q10 deficiency associated with ataxia and respiratory chain dysfunction due to novel pathogenic COQ8A variants, including a large intragenic deletion.

    Cotta A, Alston CL, Baptista-Junior S, et al.

    JIMD reports 2020; (54(1)):45-53 doi:10.1002/jmd2.12107.

    PMID: 32685350
  7. 7

    Primary CoQ10 deficiency with a severe phenotype due to the c.901 C > T (p.R301W) mutation in the COQ8A gene.

    Değerliyurt A, Gülleroğlu NB, Kibar Gül AE

    The International journal of neuroscience 2024; (134(2)):148-152 doi:10.1080/00207454.2022.2095269.

    PMID: 35757998
  8. 8

    Intermittent ketogenic fasting with medium-chain triglycerides improves ataxia in COQ8A-related coenzyme Q10 deficiency: A case report.

    Hahn W, Erffmeier K, Schulze M, et al.

    Molecular genetics and metabolism reports 2026; (46()):101296 doi:10.1016/j.ymgmr.2026.101296.

    PMID: 41716779
  9. 9

    Identification of International Classification of Functioning, Disability and Health categories in a multifaceted rehabilitation program for degenerative cerebellar ataxia: a descriptive analysis of real-world clinical practice.

    Hiramatsu Y, Fujimoto H, Otomune H, et al.

    Disability and rehabilitation 2026; (48(21)):6961-6979 doi:10.1080/09638288.2026.2646108.

    PMID: 41904646
  10. 10

    Clinico-Genetic, Imaging and Molecular Delineation of COQ8A-Ataxia: A Multicenter Study of 59 Patients.

    Traschütz A, Schirinzi T, Laugwitz L, et al.

    Annals of neurology 2020; (88(2)):251-263 doi:10.1002/ana.25751.

    PMID: 32337771
  11. 11

    Primary coenzyme Q10 deficiency due to COQ8A gene mutations.

    Zhang L, Ashizawa T, Peng D

    Molecular genetics & genomic medicine 2020; (8(10)):e1420 doi:10.1002/mgg3.1420.

    PMID: 32743982
  12. 12

    Goal-Directed Rehabilitation Versus Standard Care for Individuals with Hereditary Cerebellar Ataxia: A Multicenter, Single-Blind, Randomized Controlled Superiority Trial.

    Milne SC, Roberts M, Williams S, et al.

    Annals of neurology 2025; (97(3)):409-424 doi:10.1002/ana.27130.

    PMID: 39520242
  13. 13

    Effects of physiotherapy on degenerative cerebellar ataxia: a systematic review and meta-analysis.

    Matsugi A, Bando K, Kondo Y, et al.

    Frontiers in neurology 2024; (15()):1491142 doi:10.3389/fneur.2024.1491142.

    PMID: 39866519
  14. 14

    Home Training for Cerebellar Ataxias: A Randomized Clinical Trial.

    Barbuto S, Lee S, Stein J, et al.

    JAMA neurology 2025; (82(11)):1162-1170 doi:10.1001/jamaneurol.2025.3421.

    PMID: 40946705
  15. 15

    Home Aerobic Training for Cerebellar Degenerative Diseases: a Randomized Controlled Trial.

    Barbuto S, Kuo SH, Winterbottom L, et al.

    Cerebellum (London, England) 2023; (22(2)):272-281 doi:10.1007/s12311-022-01394-4.

    PMID: 35303255
  16. 16

    Speech and swallowing abnormalities in adults with POLG associated ataxia (POLG-A).

    Vogel AP, Rommel N, Oettinger A, et al.

    Mitochondrion 2017; (37()):1-7 doi:10.1016/j.mito.2017.06.002.

    PMID: 28634151
  17. 17

    Dysphagia in Friedreich Ataxia.

    Keage MJ, Delatycki MB, Gupta I, et al.

    Dysphagia 2017; (32(5)):626-635 doi:10.1007/s00455-017-9804-4.

    PMID: 28474131
  18. 18

    International consensus (ICON) on assessment of oropharyngeal dysphagia.

    Espitalier F, Fanous A, Aviv J, et al.

    European annals of otorhinolaryngology, head and neck diseases 2018; (135(1S)):S17-S21 doi:10.1016/j.anorl.2017.12.009.

    PMID: 29396225
  19. 19

    Features of speech and swallowing dysfunction in pre-ataxic spinocerebellar ataxia type 2.

    Vogel AP, Magee M, Torres-Vega R, et al.

    Neurology 2020; (95(2)):e194-e205 doi:10.1212/WNL.0000000000009776.

    PMID: 32527970
  20. 20

    [Clinical case of MELAS syndrom].

    Goldobin VV, Klocheva EG, Afanasyeva MY, Tertyshnaya NM

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2022; (122(6)):152-158 doi:10.17116/jnevro2022122061152.

    PMID: 35758962
  21. 21

    Expanding the Clinical and Genetic Landscape of UQCRC2-related Mitochondrial Complex III Deficiency: A Case Report and Literature Review.

    Bindi V, Crespo C, García F, et al.

    Current pediatric reviews 2026; doi:10.2174/0115733963454034260430145544.

    PMID: 42163747

This page is for informational purposes about managing COQ8A-related ataxia and does not constitute medical advice. Ask your neurologist and metabolic, therapy, heart, and kidney specialists to tailor monitoring, exercise, swallowing evaluation, and emergency planning to your situation.

Guide contents Autosomal recessive ataxia due to ubiquinone deficiency
Research & Literature
04 CoQ10 Supplementation 06 Monitoring Your Journey